Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Aide

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|July 14, 2012
The motivations and methodology for high-throughput PET imaging of small animals in cancer researchNicolas Aide, Eric P Visser, Stéphanie Lheureux, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2018
FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literatureNicolas Aide, Rodney J Hicks, Christophe Le Tourneau, et al.
EJNMMI Research|December 31, 2018
Implications of reconstruction protocol for histo-biological characterisation of breast cancers using FDG-PET radiomicsNicolas Aide, Thibault Salomon, Cécile Blanc-Fournier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 18, 2015
Patient's weight: a neglected cause of variability in SUV measurements? A survey from an EARL accredited PET centre in 513 patientsCharline Lasnon, Benjamin Houdu, Emmanuel Kammerer, et al.
Nuclear Medicine Communications|February 28, 2007
Influence of CA 15-3 blood level and doubling time on diagnostic performances of 18F-FDG PET in breast cancer patients with occult recurrenceNicolas Aide, Virginie Huchet, Odile Switsers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2017
Does PET Reconstruction Method Affect Deauville Score in Lymphoma Patients?Blandine Enilorac, Charline Lasnon, Cathy Nganoa, et al.
Haematologica|March 4, 2014
The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteriaElske Quak, Narinée Hovhannisyan, Charline Lasnon, et al.
Seminars in Nuclear Medicine|November 26, 2021
Advances in PET/CT Technology: An UpdateNicolas Aide, Charline Lasnon, Cedric Desmonts, et al.
Molecular Imaging and Biology|August 6, 2005
6-[F-18]fluoro-L-DOPA positron emission tomography in the imaging of Merkel cell carcinoma: preliminary report of three cases with 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography or pentetreotide-(111In) SPECT dataJean-Noël Talbot, Khaldoun Kerrou, Filda Missoum, et al.
Diagnostics (Basel, Switzerland)|September 28, 2024
[18F]FDG PET/CT Integration in Evaluating Immunotherapy for Lung Cancer: A Clinician's Practical ApproachJuliette Brezun, Nicolas Aide, Evelyne Peroux, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
European Journal of Nuclear Medicine and Molecular Imaging|July 14, 2012
The motivations and methodology for high-throughput PET imaging of small animals in cancer researchNicolas Aide, Eric P Visser, Stéphanie Lheureux, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2018
FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literatureNicolas Aide, Rodney J Hicks, Christophe Le Tourneau, et al.
EJNMMI Research|December 31, 2018
Implications of reconstruction protocol for histo-biological characterisation of breast cancers using FDG-PET radiomicsNicolas Aide, Thibault Salomon, Cécile Blanc-Fournier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 18, 2015
Patient's weight: a neglected cause of variability in SUV measurements? A survey from an EARL accredited PET centre in 513 patientsCharline Lasnon, Benjamin Houdu, Emmanuel Kammerer, et al.
Nuclear Medicine Communications|February 28, 2007
Influence of CA 15-3 blood level and doubling time on diagnostic performances of 18F-FDG PET in breast cancer patients with occult recurrenceNicolas Aide, Virginie Huchet, Odile Switsers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2017
Does PET Reconstruction Method Affect Deauville Score in Lymphoma Patients?Blandine Enilorac, Charline Lasnon, Cathy Nganoa, et al.
Haematologica|March 4, 2014
The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteriaElske Quak, Narinée Hovhannisyan, Charline Lasnon, et al.
Seminars in Nuclear Medicine|November 26, 2021
Advances in PET/CT Technology: An UpdateNicolas Aide, Charline Lasnon, Cedric Desmonts, et al.
Molecular Imaging and Biology|August 6, 2005
6-[F-18]fluoro-L-DOPA positron emission tomography in the imaging of Merkel cell carcinoma: preliminary report of three cases with 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography or pentetreotide-(111In) SPECT dataJean-Noël Talbot, Khaldoun Kerrou, Filda Missoum, et al.
Diagnostics (Basel, Switzerland)|September 28, 2024
[18F]FDG PET/CT Integration in Evaluating Immunotherapy for Lung Cancer: A Clinician's Practical ApproachJuliette Brezun, Nicolas Aide, Evelyne Peroux, et al.
Pageof 12